Members of the Supervisory HADJ DJEMAÏ and Strategic Orientation ANTOINE MORANDI (52 years old) SANDRINE AVELANGE (37 years old) Board (CSOS) (55 years old) Representative of Representative of Representing Sagesse Intermediate Capital Group Intermediate Capital Group Retraite Santé (SRS) (ICG) (ICG) Sandrine Avelange joined the SAGESSE Group in 2011 Antoine Morandi joined ICG in 2019 and is anHadj Djemaï joined ICG in June 2000 and is Head of YVES JOURNEL after serving as Chief Financial Officer of the medical associate director in the European SubordinatedSouthern Europe, European Corporate and a member (75 years old) and social services division of Compagnie Générale Debt and Equity team based in Paris. He joinedof the Investment Strategy Committee. He joined ICG Chairman of the Supervisory de Santé (now Ramsay Group) and then DomusVi. ICG after working for eight years at Lazard in the after working in the acquisition finance group at BNP and StrategicGuidance Board A graduate of Sup de Co Marseille, holder of a Paris office. A graduate of HEC Paris with an MSC in Paribas. Hadj Djemaï holds an engineering degree (representing SAGESSE) D.E.S.C.A.F. and an IFA-Sciences Po Company International Finance, Antoine Morandi is a director from the Institut national agronomique de Paris and Director Certificate, Sandrine Avelange is Chair of of IGZ Topco (Picard) and a non-voting member ofis a member of the supervisory boards of Oak Nation Yves Journel founded the DomusVi Group in 1983;the Board of Directors and Audit Committee of Santé Circet Holding (Circet. H)e is also a member of the SAS (Charlois Group), CMAI Holding, IGZ Topco he developed, managed and chaired it until 2010.Sedna (Canada) and SRS representative on the Audit Committee of Colombe Holding (DomusVi). (Picard) and Biogroup Holding. He is Chairman of Since 2010, he has been Chairman of the Supervi-Supervisory Board of Colombe Holding (DomusVi). the Supervisory Committee of Circet, ICG’s repre- sory and Strategic Orientation Board (reresentingp She is also President of the Audit Committee of sentative on the Supervisory Board of Polaris Holding SAGESSE) and the founding and family sharehol-Colombe Holding (DomusVi). SAS (Stella) and observer of IngraGroup Bidco S.à r.l. der. Involved in the management of private (Luxembourg). He is also Chairman of the Acquisi- healthcare and medico-socialactivities since tions Committee and a member of the Appointments 1977, Yves Journel participated in the creation and JAÏME CHROCRÓN and Remuneration Committee of Colombe Holding development of Compagnie Générale de Santé (41 years old) (DomusVi). (taken over by Ramsay) between 1987 and 1997. Representative of He also contributed to the development of profes- THIERRY CHIGNON Intermediate Capital Group sional organisations in the private medico-social (59 years old) (ICG) services sector in France, chairing Uneppa from 1991 Representative of Mérieux to 2000 and then Synerpa from 2004 to 2009. Equity Partners Jaime Chrocrón joined ICG in 2008. He is currently Yves Journel is Chairman of SAGESSE. He repre- Managing Director and Head of Iberia. Previously, THIERRY BÉLIARD sents SAGESSE as Chairman of the Supervisory andThierry Chignon joined Mérieux Equity Partners in he worked for four years in the Investment Banking (49 years old) Strategic Orientation Board of Colombe Holding2014 as Senior Partner. Previously, he was Managing division of JP Morgan in London, first in the Struc- Representative of SAS (DomusVi), SRS Holding SAS, SIDVH SAS,Director of Quintiles Consulting Europe (now IQVIA) tured Finance group and then in the M&A Consumer, Intermediate Capital Group SI AlmaVi SAS, Almaviva Santé SAS, Sedna Santé SAS, and worked at Matignon Investissement. With over Retail & Healthcare group. Jaime Chrocrón began his (ICG) Sedna France SAS, Arenadour Capital SAS and Apt30 years’ experience in the healthcare industry, career at Goldman Sachs and Santander Investment. RenaissanceSAS. He is Chairman of the Board ofparticularly in the medical devices sector, as Chief Jaime Chrocrón holds a degree in BusinessThierry Béliard is Director within ICG’s European Directors of GP Sedna Canada Sedna Santé (Canada), Pharmacist at the Institut Mérieux (now Sanofi Administration from ICADE University in MadridSubordinated Debt & Equity Team. Thierry Béliard Pasteur) or as an expert advisor to the European and is a director of Parsina Investments S.L.joined ICG in 2019 after working for seven years at SAGESSE, represented by Yves Journel, is alsoCommission (medical devices), Thierry Chignon (Alvinesa), Productos Sur S.L. (Prosur) and Grupo the Boston Consultin Group, then as a director atg Chairman of the Nominations and Remunerationsholds a bachelor’s degree in pharmacy, a master’s J. Uriach, S.L.U. (Uriach). He is also a director and Chequers Capital and for five years for the Abu Dhabi Committee and of the Purpose & Sustainabledegree from IEP Paris (Political Science) and an Vice-Chairman of the Board of Directors of Kronosnet Investment Authority (ADIA). A graduate of the Ecole Development Committee and a member of the Acqui-executive MBA from HEC Paris. He is Chairman of Topco S.L. (Konecta). Polytechnique de Paris with an MBA from Harvard sitions Committee of Colombe Holding (DomusVi). the Supervisory Board of Plantex, of the Board of Business School, Thierry Béliard is a member of the Yves Journel is a director and member of the Synerpa Directors of Airinspace and a director of Elsan, supervisory boards Oak Nation (Charlois Group) Biofirst and Seqens and a non-voting member of INFRAGROUP BIDCO executive committee. S.à r.l. (Luxembourg). He is also a member of the Audit Committee, the Nomination and Remuneration Committee and the Purpose and Sustainable Deve- lopment Committee of Colombe Holding (DomusVi). 22 23 4202 TROPER YTILIBANIATSUSPUORG RUO